Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2400167122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Stephanie Pei Tung Yiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Receptors, Antigen, B-Cell, Endoplasmic Reticulum-Associated Degradation, Viral Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UKRI | Medical Research Council (MRC), HHS | National Institutes of Health (NIH), NIAID NIH HHS.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) establishes persistent infection, causes infectious mononucleosis, is a major trigger for multiple sclerosis and contributes to multiple cancers. Yet, knowledge remains incomplete about how the virus remodels host B cells to support lytic replication. We previously identified that EBV lytic replication results in selective depletion of plasma membrane (PM) B cell receptor (BCR) complexes, composed of immunoglobulin and the CD79A and CD79B signaling chains. Here, we used proteomic and biochemical approaches to identify that the EBV early lytic protein BALF0/1 is responsible for EBV lytic cycle BCR degradation. Mechanistically, an immunoglobulin heavy chain (HC) cytoplasmic tail KVK motif was required for ubiquitin-mediated BCR degradation, while CD79A and CD79B were dispensable. BALF0/1 subverted caveolin-mediated endocytosis to internalize PM BCR complexes and to deliver them to the endoplasmic reticulum. BALF0/1 stimulated immunoglobulin HC cytoplasmic tail ubiquitination, which together with the ATPase valosin-containing protein/p97 drove ER-associated degradation of BCR complexes by cytoplasmic proteasomes. BALF0/1 knockout reduced the viral load of secreted EBV particles from B cells that expressed a monoclonal antibody against EBV glycoprotein 350 but not a control anti-influenza hemagglutinin antibody and increased viral particle immunoglobulin incorporation. Consistent with downmodulation of PM BCR, BALF0/1 overexpression reduced viability of a diffuse large B cell lymphoma cell line whose survival is dependent upon BCR signaling. Collectively, our results suggest that EBV BALF0/1 downmodulates immunoglobulin upon lytic reactivation to block BCR signaling and support virion release, but await the development of suitable models to test its roles in EBV reactivation in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
- Harvard Graduate Program in Virology, Boston, MA 02115.
- Center for Integrated Solutions to Infectious Diseases, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142.
- Department of Microbiology, Harvard Medical School, Boston, MA 02115.
- Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom.
ORCID-Profile: Yifei Liao, Jinjie Yan, Michael P Weekes, Benjamin E Gewurz
Förderung
- UKRI | Medical Research Council (MRC)
- HHS | National Institutes of Health (NIH)
- NIAID NIH HHS
- NCI NIH HHS
- Wellcome Trust Institutional Strategic Support Fund
- Wellcome Trust
Zitieren
APA
Yiu, S. P. T., Liao, Y., Yan, J., Weekes, M. P., & Gewurz, B. E. (2025). Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2400167122
Vancouver
Yiu SPT, Liao Y, Yan J, Weekes MP, Gewurz BE. Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2400167122
BibTeX
@article{Yiu2025,
author = {Yiu, Stephanie Pei Tung and Liao, Yifei and Yan, Jinjie and Weekes, Michael P and Gewurz, Benjamin E},
title = {Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2400167122}
}
EUVIMED